Literature DB >> 30054205

PD-1 Inhibitory Receptor Downregulates Asparaginyl Endopeptidase and Maintains Foxp3 Transcription Factor Stability in Induced Regulatory T Cells.

Chaido Stathopoulou1, Arunakumar Gangaplara2, Grace Mallett1, Francis A Flomerfelt3, Lukasz P Liniany1, David Knight4, Leigh A Samsel5, Rolando Berlinguer-Palmini1, Joshua J Yim6, Tania C Felizardo3, Michael A Eckhaus7, Laura Edgington-Mitchell8, Jonathan Martinez-Fabregas9, Jinfang Zhu2, Daniel H Fowler3, Sander I van Kasteren10, Arian Laurence11, Matthew Bogyo6, Colin Watts9, Ethan M Shevach2, Shoba Amarnath12.   

Abstract

CD4+ T cell differentiation into multiple T helper (Th) cell lineages is critical for optimal adaptive immune responses. This report identifies an intrinsic mechanism by which programmed death-1 receptor (PD-1) signaling imparted regulatory phenotype to Foxp3+ Th1 cells (denoted as Tbet+iTregPDL1 cells) and inducible regulatory T (iTreg) cells. Tbet+iTregPDL1 cells prevented inflammation in murine models of experimental colitis and experimental graft versus host disease (GvHD). Programmed death ligand-1 (PDL-1) binding to PD-1 imparted regulatory function to Tbet+iTregPDL1 cells and iTreg cells by specifically downregulating endo-lysosomal protease asparaginyl endopeptidase (AEP). AEP regulated Foxp3 stability and blocking AEP imparted regulatory function in Tbet+iTreg cells. Also, Aep-/- iTreg cells significantly inhibited GvHD and maintained Foxp3 expression. PD-1-mediated Foxp3 maintenance in Tbet+ Th1 cells occurred both in tumor infiltrating lymphocytes (TILs) and during chronic viral infection. Collectively, this report has identified an intrinsic function for PD-1 in maintaining Foxp3 through proteolytic pathway.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  AEP; Foxp3; GvHD; LCMV; PD-1; PDL-1; colitis; iTreg; melanoma

Mesh:

Substances:

Year:  2018        PMID: 30054205      PMCID: PMC6105434          DOI: 10.1016/j.immuni.2018.05.006

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  52 in total

1.  Regulatory T cell responses develop in parallel to Th responses and control the magnitude and phenotype of the Th effector population.

Authors:  Justin J Taylor; Markus Mohrs; Edward J Pearce
Journal:  J Immunol       Date:  2006-05-15       Impact factor: 5.422

2.  Epigenetic instability of cytokine and transcription factor gene loci underlies plasticity of the T helper 17 cell lineage.

Authors:  Ryuta Mukasa; Anand Balasubramani; Yun Kyung Lee; Sarah K Whitley; Benjamin T Weaver; Yoichiro Shibata; Gregory E Crawford; Robin D Hatton; Casey T Weaver
Journal:  Immunity       Date:  2010-05-13       Impact factor: 31.745

3.  Interferons direct Th2 cell reprogramming to generate a stable GATA-3(+)T-bet(+) cell subset with combined Th2 and Th1 cell functions.

Authors:  Ahmed N Hegazy; Michael Peine; Caroline Helmstetter; Isabel Panse; Anja Fröhlich; Andreas Bergthaler; Lukas Flatz; Daniel D Pinschewer; Andreas Radbruch; Max Löhning
Journal:  Immunity       Date:  2010-01-14       Impact factor: 31.745

Review 4.  Endo-lysosomal proteases in antigen presentation.

Authors:  Sander I van Kasteren; Herman S Overkleeft
Journal:  Curr Opin Chem Biol       Date:  2014-09-15       Impact factor: 8.822

5.  Nucleoplasmic calcium regulates cell proliferation through legumain.

Authors:  Viviane Andrade; Mateus Guerra; Camila Jardim; Flavia Melo; Wamberto Silva; Jose M Ortega; Marie Robert; Michael H Nathanson; Fatima Leite
Journal:  J Hepatol       Date:  2011-01-13       Impact factor: 25.083

Review 6.  Mechanisms underlying lineage commitment and plasticity of helper CD4+ T cells.

Authors:  John J O'Shea; William E Paul
Journal:  Science       Date:  2010-02-26       Impact factor: 47.728

7.  T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gamma.

Authors:  Xuexian O Yang; Bhanu P Pappu; Roza Nurieva; Askar Akimzhanov; Hong Soon Kang; Yeonseok Chung; Li Ma; Bhavin Shah; Athanasia D Panopoulos; Kimberly S Schluns; Stephanie S Watowich; Qiang Tian; Anton M Jetten; Chen Dong
Journal:  Immunity       Date:  2007-12-27       Impact factor: 31.745

8.  Self-antigen-driven activation induces instability of regulatory T cells during an inflammatory autoimmune response.

Authors:  Samantha L Bailey-Bucktrout; Marc Martinez-Llordella; Xuyu Zhou; Bryan Anthony; Wendy Rosenthal; Herve Luche; Hans J Fehling; Jeffrey A Bluestone
Journal:  Immunity       Date:  2013-11-14       Impact factor: 31.745

9.  Therapeutic PD-1 pathway blockade augments with other modalities of immunotherapy T-cell function to prevent immune decline in ovarian cancer.

Authors:  Jaikumar Duraiswamy; Gordon J Freeman; George Coukos
Journal:  Cancer Res       Date:  2013-08-23       Impact factor: 12.701

10.  Nuclear legumain activity in colorectal cancer.

Authors:  Mads H Haugen; Harald T Johansen; Solveig J Pettersen; Rigmor Solberg; Klaudia Brix; Kjersti Flatmark; Gunhild M Maelandsmo
Journal:  PLoS One       Date:  2013-01-10       Impact factor: 3.240

View more
  33 in total

1.  Role of Asparagine Endopeptidase in Mediating Wild-Type p53 Inactivation of Glioblastoma.

Authors:  Yingying Lin; Keman Liao; Yifeng Miao; Zhongrun Qian; Zhaoyuan Fang; Xi Yang; Quanmin Nie; Gan Jiang; Jianhua Liu; Yiyi Yu; Jieqing Wan; Xiaohua Zhang; Yaomin Hu; Jiyao Jiang; Yongming Qiu
Journal:  J Natl Cancer Inst       Date:  2020-04-01       Impact factor: 13.506

Review 2.  Adverse Events Following Cancer Immunotherapy: Obstacles and Opportunities.

Authors:  Kristen E Pauken; Michael Dougan; Noel R Rose; Andrew H Lichtman; Arlene H Sharpe
Journal:  Trends Immunol       Date:  2019-04-30       Impact factor: 16.687

3.  Clinicopathological analysis of neoplastic PD-L1-positive EBV+ diffuse large B cell lymphoma, not otherwise specified, in a Japanese cohort.

Authors:  Taishi Takahara; Akira Satou; Eri Ishikawa; Kei Kohno; Seiichi Kato; Yuka Suzuki; Emiko Takahashi; Akiko Ohashi; Naoko Asano; Toyonori Tsuzuki; Shigeo Nakamura
Journal:  Virchows Arch       Date:  2020-08-15       Impact factor: 4.064

4.  PTCy ameliorates GVHD by restoring regulatory and effector T-cell homeostasis in recipients with PD-1 blockade.

Authors:  Shuntaro Ikegawa; Yusuke Meguri; Takumi Kondo; Hiroyuki Sugiura; Yasuhisa Sando; Makoto Nakamura; Miki Iwamoto; Yoshinobu Maeda; Ken-Ichi Matsuoka
Journal:  Blood Adv       Date:  2019-12-10

5.  Haploidentical mixed chimerism cures autoimmunity in established type 1 diabetic mice.

Authors:  Yuqing Liu; Xiaoqi Wang; Yongping Zhu; Mingfeng Zhang; Ubaydah Nasri; Sharne S Sun; Stephen J Forman; Arthur D Riggs; Xi Zhang; Defu Zeng
Journal:  J Clin Invest       Date:  2020-12-01       Impact factor: 14.808

Review 6.  Antigen-Specific Regulatory T Cell Therapy in Autoimmune Diseases and Transplantation.

Authors:  Claudia Selck; Margarita Dominguez-Villar
Journal:  Front Immunol       Date:  2021-05-14       Impact factor: 7.561

7.  Inhibition of LSD1 Attenuates Oral Cancer Development and Promotes Therapeutic Efficacy of Immune Checkpoint Blockade and YAP/TAZ Inhibition.

Authors:  Thabet Alhousami; Michael Diny; Faiza Ali; Jennifer Shin; Gaurav Kumar; Vikas Kumar; Joshua D Campbell; Vikki Noonan; Glenn J Hanna; Gerald V Denis; Stefano Monti; Maria A Kukuruzinska; Xaralabos Varelas; Manish V Bais
Journal:  Mol Cancer Res       Date:  2022-05-04       Impact factor: 6.333

8.  Retrospective analysis of antitumor effects and biomarkers for nivolumab in NSCLC patients with EGFR mutations.

Authors:  Miyuki Sato; Satoshi Watanabe; Hiroshi Tanaka; Koichiro Nozaki; Masashi Arita; Miho Takahashi; Satoshi Shoji; Kosuke Ichikawa; Rie Kondo; Nobumasa Aoki; Masachika Hayashi; Yasuyoshi Ohshima; Toshiyuki Koya; Riuko Ohashi; Yoichi Ajioka; Toshiaki Kikuchi
Journal:  PLoS One       Date:  2019-04-12       Impact factor: 3.240

9.  Asparaginyl Endopeptidase (Legumain) Supports Human Th1 Induction via Cathepsin L-Mediated Intracellular C3 Activation.

Authors:  Simon Freeley; John Cardone; Sira C Günther; Erin E West; Thomas Reinheckel; Colin Watts; Claudia Kemper; Martin V Kolev
Journal:  Front Immunol       Date:  2018-10-24       Impact factor: 7.561

Review 10.  The Mechanism of Asparagine Endopeptidase in the Progression of Malignant Tumors: A Review.

Authors:  Wenrui Zhang; Yingying Lin
Journal:  Cells       Date:  2021-05-10       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.